Repligen Corp

1RGEN

Company Profile

  • Business description

    Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

  • Contact

    41 Seyon Street
    Building 1, Suite 100
    WalthamMA02453
    USA

    T: +1 781 250-0111

    E: [email protected]

    https://www.repligen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    2,000

Stocks News & Analysis

stocks

ASX data center shares remain cheap after downgrade

Near-term pain, long-term potential.
stocks

Meta earnings: Early look at Muse adoption impresses investors

We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.
stocks

Tesla earnings: Shares fall on slower deliveries growth outlook; Raising valuation

Our increased valuation comes from higher full self-driving adoption assumptions and a lower near- and medium-term capital expenditures forecast.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,905.8011.30-0.13%
CAC 407,782.8228.44-0.36%
DAX 4025,181.65190.10-0.75%
Dow JONES (US)52,215.16652.82-1.23%
FTSE 10010,690.3634.67-0.32%
HKSE23,093.37158.690.69%
NASDAQ25,955.3453.52-0.21%
Nikkei 22562,693.16214.68-0.34%
NZX 50 Index13,733.9312.91-0.09%
S&P 5007,623.6839.75-0.52%
S&P/ASX 2008,795.202.000.02%
SSE Composite Index3,690.4832.450.89%

Market Movers